DAFNA Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-135,850
| Closed | -$701K | – | 88 |
|
|
2024
Q2 | $701K | Hold |
135,850
| – | – | 0.17% | 69 |
|
|
2024
Q1 | $727K | Sell |
135,850
-79,035
| -37% | -$423K | 0.17% | 64 |
|
|
2023
Q4 | $1.67M | Sell |
214,885
-50,993
| -19% | -$397K | 0.4% | 49 |
|
|
2023
Q3 | $1.05M | Hold |
265,878
| – | – | 0.33% | 56 |
|
|
2023
Q2 | $838K | Hold |
265,878
| – | – | 0.23% | 55 |
|
|
2023
Q1 | $710K | Hold |
265,878
| – | – | 0.21% | 55 |
|
|
2022
Q4 | $955K | Hold |
265,878
| – | – | 0.27% | 52 |
|
|
2022
Q3 | $1.71M | Buy |
+265,878
| New | +$1.71M | 0.46% | 45 |
|